147 related articles for article (PubMed ID: 38051842)
21. Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
Au JH; Hooper PB; Fitzgerald AL; Somani AK
Dermatol Ther (Heidelb); 2022 Feb; 12(2):591-597. PubMed ID: 34951694
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma.
Arron ST; Wysong A; Hall MA; Bailey CN; Covington KR; Kurley SJ; Goldberg MS; Kasprzak JM; Somani AK; Ibrahim SF; Brodland DG; Cleaver NJ; Maher IA; Xia Y; Koyfman SA; Newman JG
Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):135-144. PubMed ID: 35155791
[TBL] [Abstract][Full Text] [Related]
23. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Masarwy R; Shilo S; Carmel Neiderman NN; Kampel L; Horowitz G; Muhanna N; Mansour J
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173922
[TBL] [Abstract][Full Text] [Related]
25. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD
Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854
[TBL] [Abstract][Full Text] [Related]
26. Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Borman S; Wilkinson J; Meldi-Sholl L; Johnson C; Carter K; Covington KR; Fitzgerald AL; Kurley SJ; Farberg AS; Goldberg MS; Monzon FA; Oelschlager K; Cook RW
Diagn Pathol; 2022 Feb; 17(1):32. PubMed ID: 35216597
[TBL] [Abstract][Full Text] [Related]
27. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
28. Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel.
Zakria D; Brownstone N; Armstrong AW; Boh EE; Koo JYM; Merola JF; Pariser D; Lebwohl M
J Drugs Dermatol; 2023 Jun; 22(6):588-593. PubMed ID: 37276166
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test.
Mirsky R; Prado G; Svoboda R; Glazer A; Rigel D
J Drugs Dermatol; 2018 Nov; 17(11):1220-1223. PubMed ID: 30500144
[TBL] [Abstract][Full Text] [Related]
31. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults.
Dinnes J; Deeks JJ; Chuchu N; Matin RN; Wong KY; Aldridge RB; Durack A; Gulati A; Chan SA; Johnston L; Bayliss SE; Leonardi-Bee J; Takwoingi Y; Davenport C; O'Sullivan C; Tehrani H; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011901. PubMed ID: 30521688
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.
Wang J; Harwood CA; Bailey E; Bewicke-Copley F; Anene CA; Thomson J; Qamar MJ; Laban R; Nourse C; Schoenherr C; Treanor-Taylor M; Healy E; Lai C; Craig P; Moyes C; Rickaby W; Martin J; Proby C; Inman GJ; Leigh IM
J Am Acad Dermatol; 2023 Dec; 89(6):1159-1166. PubMed ID: 37586461
[TBL] [Abstract][Full Text] [Related]
33. Guidelines of care for the management of cutaneous squamous cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
[TBL] [Abstract][Full Text] [Related]
35. Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma.
Dessinioti C; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():11-18. PubMed ID: 34855249
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
37. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Wysong A; Somani AK; Ibrahim SF; Cañueto J; Fitzgerald AL; Siegel JJ; Prasai A; Goldberg MS; Farberg AS; Regula C; Bar A; Kasprzak J; Brodland DG; Koyfman SA; Arron ST
Dermatol Ther (Heidelb); 2024 Mar; 14(3):593-612. PubMed ID: 38424384
[TBL] [Abstract][Full Text] [Related]
38. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
Queirolo P; Cinquini M; Argenziano G; Bassetto F; Bossi P; Boutros A; Clemente C; de Giorgi V; Del Vecchio M; Patuzzo R; Pennachioli E; Peris K; Quaglino P; Reali A; Zalaudek I; Spagnolo F
ESMO Open; 2024 May; 9(5):103005. PubMed ID: 38688192
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines.
Peris K; Alaibac M; Argenziano G; Di Stefani A; Fargnoli MC; Frascione P; Gualdi G; Longo C; Moscarella E; Naldi L; Pellacani G; Pimpinelli N; Quaglino P; Salgarello M; Sollena P; Valentini V; Zalaudek I; Calzavara-Pinton PG;
G Ital Dermatol Venereol; 2018 Dec; 153(6):747-762. PubMed ID: 29898593
[TBL] [Abstract][Full Text] [Related]
40. Methodology for the systematic reviews on an adjacent segment pathology.
Norvell DC; Dettori JR; Skelly AC; Riew KD; Chapman JR; Anderson PA
Spine (Phila Pa 1976); 2012 Oct; 37(22 Suppl):S10-7. PubMed ID: 22872224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
